A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

Completed · Phase 3

Conditions studied: HCV Negative Status, HCV Risk Behavior

In brief

The purpose of this study is to examine the efficacy of a brief motivational intervention on the cumulative incidence of Hepatitis C.

Key facts

Study ID

NCT00218192

Run by

Butler Hospital

People needed

277

Starts

2000-09-01

Expected to finish

2006-11-01

Last updated by the study team

2015-05-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• current opiate or cocaine use
• HCV seronegative
• able to complete the study procedures in English

You may not qualify if…

• current enrollment in a formal substance abuse treatment program

Where it is running

• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.